Breast Benign and Malignant Flashcards

1
Q

What are the boundaries of the breast tissue on the body?

A
  • from infraclavicular space to inframammary fold

- from sternum to latissimus dorsi and axilla

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are you looking for on the breast physical exam?

A
  • overall shape, symmetry
  • lump: note location, size, mobility, shape
  • nipple discharge
  • skin: dimpling, retraction, erythema, nipple crusting, peau d’orange
  • lymph nodes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Screening Mammography Recommendations

A
  • yearly age 50-75
  • screening during 40s and after 75 at discretion of pt and provider
  • high risk: start screening 10 years earlier than age at which youngest relative was diagnosed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Diagnostic Mammogram

A
  • done if screening mammo is abnormal
  • clinical exam finding: mass, pain, discharge
  • BIRADS score 1-4 based on level of suspicion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Ultrasound

A
  • adjunct to diagnostic mammo

- primary diagnostic tool in pts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MRI

A
  • high risk pts: previous CA, dense breasts, significant family hx
  • higher false positive rate than mammogram
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are causes of benign histology from the breast?

A
  • fibrofatty tissue
  • fibrocystic change: fibrosis, cysts, hyperplasia, metaplasia
  • fibroadenoma
  • simple cysts
  • phyllodes tumor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Atypical Ductal Hyperplasia

A
  • precursor to invasive carcinoma 4-5x increased risk

- requires excision w/ clear margin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is fibrocystic change?

A

-normal change that occurs in the breast in response to hormones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are symptoms of fibrocystic change?

A
  • lumpy breasts
  • tenderness, esp at menstruation
  • may have significant non-cyclic pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Treatment of Fibrocystic Change

A
  • reassurance
  • NSAIDs for pain
  • change or stop OCPs
  • vit B complex
  • fish oil
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is a fibroadenoma?

A
  • most common solid mass in women of reproductive years
  • benign w/ no increased CA risk
  • may be multiple and recurrent
  • firm, round, well-circumscribed, mobile mass
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How is a fibroadenoma diagnosed and treated?

A
  • Dx: classic US and/or needle biopsy

- Tx: does not require excision, but most pts prefer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Nipple Discharge

A
  • usually a benign process
  • may be clear, milky, greenish, bloody
  • bilateral milky may be galactorrhea (check for pg or high prolactin levels)
  • clear or greenish is normal
  • bloody usually due to intraductal papilloma (benign growth)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Causes of Mastitis/Abscess

A
  • pregnancy, lactation
  • injury
  • nipple piercing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Sxs of Mastitis

A
  • pain

- swollen, erythematous breast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Tx of Mastitis

A
  • antibiotics
  • mammogram to R/O abscess
  • percutaneous aspiration of abscess
  • if no abscess identified and abx don’t clear infx, refer to surgeon for biopsy to R/O inflammatory breast CA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What group is at risk of recurrent retroareolar infections?

19
Q

Breast Cancer

A
  • most common CA in women
  • 2nd leading cause of CA death
  • incidence increasing, mortality decreasing
20
Q

Risk Factors for Breast CA

A
  • early menarche or late menopause
  • first birth after 30 or nulliparity
  • family hx
  • atypical hyperplasia or LCIS
  • known carrier of BRCA 1 or 2
  • personal hx of ovarian, colon, uterine CA
  • hormone replacement therapy
21
Q

LCIS

A
  • not cancer, but a risk factor for cancer
  • incidental finding
  • tx: close observation, bilateral prophylactic mastectomy
22
Q

DCIS

A
  • usually presents as abnormal appearing microcalcifications
  • proliferation of malignant cells in ducts
  • tx: lumpectomy/radiation, mastectomy; NO lymph node dissection or chemo
23
Q

Invasive Ductal/Lobular Carcinoma

A
  • 80% of breast CA is ductal
  • lobular carcinoma more diffuse and difficult to detect on mammogram
  • lymphatic spread
  • Tx: axillary node biopsy for staging, lumpectomy/radiation or mastectomy, chemo/hormone therapy
24
Q

Inflammatory Breast CA

A
  • stage IIIb, poor prognosis
  • signs: swollen non-tender breast, erythema, peau d’orange, may not have dominant mass
  • Tx: preoperative chemo, mastectomy and axillary node dissection, radiation, hormone therapy
25
Paget's Dz
- eczematous changes of the nipple - associated w/ underlying invasive cancer - diagnosed with nipple biopsy - tx with mastectomy
26
1. Incisional Biopsy | 2. Excisional Biopsy
1. removing a piece of suspicious mass for diagnosis only | 2. completely excising mass for diagnosis; clear margins may be adequate CA surgery
27
Lumpectomy
- excision of mass and normal surrounding tissue - reserved for tx of cancers, not benign lesions - requires post-op radiation to reduce risk of recurrence
28
Mastectomy
- excision of breast tissue, pectoralis fascia, and overlying skin - option of immediate reconstruction - modified radical mastectomy includes axillary lymph nodes (usually for inflammatory)
29
Sentinel Lymph Node Biopsy
- remove only lymph nodes with highest likelihood of metastasis - radioactive dye injected - lymph nodes identified via discoloration - reduces post-op pain and risk of upper extremity lymphedema
30
Poor Prognostic Factors
- positive lymph nodes - size >2 cm - high grade - estrogen receptor negative (does not respond to hormones) - her-2 positive
31
Chemotherapy
- usually recommended if tumors >2 cm, positive lymph nodes or high risk genomic test - adriamycin/cyclophosphamid 4 cycles - taxol added if + lymph nodes or poor prognosis
32
Herceptin
- adjuvant therapy in tumors with Her2 gene overexpression | - Her2 controls cell growth and death --> herceptin binds to the Her2 receptors to make them ineffectvie
33
Tamoxifen
- competitive inhibitor of estrogen receptors | - survival advantage and decreased recurrence rates
34
Side Effects of Tamoxifen
- risk of uterine cancer - thrombotic events - hot flashes - weight gain
35
Aromatase Inhibitors (Arimidex)
- inhibits production of estrogen | - only for post-menopausal women
36
Indications for Radiation Therapy
- most pts with lumpectomy - mastectomy of tumor >5 cm - chest wall involvement - postive axillary lymph nodes
37
Therapy at Stage 0 DCIS
+/- hormone therapy
38
Therapy at Stage 1
- premenopause: tamoxifen +/- chemo | - postmenopause: arimidex
39
Therapy at Stage 2
-chemo and hormone therapy
40
Therapy at Stage 3
-chemo, hormone therapy, radiation to chest wall and lymph nodes
41
Therapy at Stage 4
-hormone therapy, radiation to metastatic dz
42
Factors Associated w/ Increased Risk of Genetic Cancer
- bilateral cancer in paired organs (breast, lung, kidney) - multiple primary CA - multifocal CA - early age of onset - CA in 2 or more relatives - Ashkenazi Jewish ancestry
43
What are 4 genetic breast cancer syndromes?
- BRCA1 - BRCA2 - Cowden (breast, gastrointestinal, thyroid) - Li Fraumeni (breast, brain, adrenal CA, sarcoma, leukemia)